SABBY MANAGEMENT, LLC

Name: SABBY MANAGEMENT, LLC: Form 13F holdings for the quarter ended 2026-06-30
Creator: Listed

An institutional investment manager in MIAMI BEACH, FL. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1535610.

Share this page

Link

Story card, 1080 × 1920

Reported value$110.5m
Positions23

Holdings: 23 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

SABBY MANAGEMENT, LLC, holdings
Issuer	Class	CUSIP	Reported value$m	Weight	Shares	Put or call	Change on the quarter before
State Street SPDR S&P	ETF	78462F953	54.1	49.0%	725	Put	Added+278
State Street SPDR S&P	ETF	78462F903	15.3	13.9%	205	Call	New+205
Ishares Russell	ETF	464287905	13.3	12.0%	442	Call	New+442
Ishares Russell	ETF	464287955	13.2	12.0%	441	Put	Added+141
State Street SPDR S&PSPY	ETF	78462F103	4.1	3.7%	5,500		Added+2,766
Toyo Co Ltd	ORD	G8976D107	3.5	3.2%	503,846		New+503,846
Abivax SA	ADS	00370M903	1.1	1.0%	82	Call	Added+5
Farmmi Inc	CL A	G33277149	0.8	0.8%	3,515,929		New+3,515,929
Sidus Space Inc	CL A	826165951	0.8	0.7%	2,905	Put	Added+1,856
Cervomed IncCRVO	COM	15713L109	0.8	0.7%	248,880		New+248,880
Zevra Therapeutics	COM	488445956	0.6	0.6%	427	Put	Added+87
Tempest Therapeutics IncTPST	COM	87978U207	0.6	0.5%	511,286		Added+493,430
Paranovus Entertnmnt Tech LT	CL A	G4289N155	0.6	0.5%	75,440		New+75,440
Bioaffinity Technologies	COM	09076W307	0.3	0.3%	365,647		New+365,647
Smart Power CorpCREG	COM	168913507	0.3	0.2%	127,774		New+127,774
Briacell Therapeutics CorpBCTX	COM	107930307	0.3	0.2%	80,721		Added+6,806
Revelation Biosciences Inc	COM	76135L804	0.2	0.2%	210,582		Added+111,150
Senestech IncSNES	COM	81720R604	0.2	0.2%	141,756		Reduced−76,777
Briacell Therapeutics CorpBCTX	*W	107930125	0.2	0.2%	190,383		Reduced−190,303
Sidus Space IncSIDU	CL A	826165201	0.1	0.1%	43,377		New+43,377
Inmed PharmaceuticalsINM	COM	457637700	0.1	<0.1%	44,970		Reduced−175,290
Nuwellis IncNUWE	COM	67113Y801	0.0	<0.1%	16,372		New+16,372
Briacell Therapeutics CorpBCTX	*W	107930117	0.0	<0.1%	120,802		Reduced−85,951

Sold out: 15 positions

Held at the end of the quarter before and not reported this quarter.

SABBY MANAGEMENT, LLC, positions sold out
Issuer	Class	CUSIP	Weight	Put or call	Change on the quarter before
Alphaton Capital Corp	SHS	G7185A136	0.0%		Sold out−2,072,103
Arcadia Biosciences IncRKDA	COM	039014303	0.0%		Sold out−114,554
Big Tree Cloud Holdings Ltd	CL A	G1263B132	0.0%		Sold out−137,611
Biodexa Pharmaceuticals plc	ADS	59564R880	0.0%		Sold out−257,472
Bluejay Diagnostics IncBJDX	COM	095633608	0.0%		Sold out−28,726
BNB Plus CorpBNBX	COM	03815U607	0.0%		Sold out−13,541
Calidi Biotherapeutics Inc	COM	320703408	0.0%		Sold out−434,903
CAN Fite Biofarma LtdCANF	ADR	13471N409	0.0%		Sold out−42,559
China SXT Pharmaceuticals Inc	CL A	G2161P165	0.0%		Sold out−78,170
Gevo Inc	COM	374396956	0.0%	Put	Sold out−5,252
Lyra Therapeutics Inc	COM	55234L204	0.0%		Sold out−104,059
Moleculin Biotech Inc	COM	60855D408	0.0%		Sold out−75,021
POP Culture Group Co Ltd	SHS	G71700119	0.0%		Sold out−664,449
Token Cat LtdTC	ADS	89856T401	0.0%		Sold out−23,239
TRX Gold CorpTRX	COM	87283P109	0.0%		Sold out−100,000

Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-096397 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.